β-methylation of the Phe7 and Trp9 melanotropin side chain pharmacophores affects ligand-receptor interactions and prolonged biological activity

Journal of Medicinal Chemistry

Volumn 40, Issue 17, 1997, Pages 2740-2749

  Haskell Luevano, Carrie ^a   Toth, Kate ^a   Boteju, Lakmal ^a   Job, Constatin ^b   Castrucci, Ana Maria De L ^c   Hadley, Mac E ^b   Hruby, Victor J ^a  

^a University of Arizona   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG CARRIER; INTERMEDIN; N METHYLTRYPTOPHAN; PHENYLALANINE; TRYPTOPHAN; HORMONE RECEPTOR; INTERMEDIN RECEPTOR; LIGAND;

AMINO ACID SUBSTITUTION; ARTICLE; CHEMICAL MODIFICATION; DRUG POTENCY; DRUG RECEPTOR BINDING; LIGAND BINDING; METHYLATION; NONHUMAN; PEPTIDE SYNTHESIS; PROTEIN PROTEIN INTERACTION; SPECIES DIFFERENCE; STRUCTURE ACTIVITY RELATION; ANIMAL; CHEMICAL MODEL; CHEMICAL STRUCTURE; CHEMISTRY; FROG; HUMAN; LIZARD; METABOLISM; STEREOISOMERISM;

ANIMALS; HUMANS; LIGANDS; LIZARDS; MELANOCYTE-STIMULATING HORMONES; METHYLATION; MODELS, CHEMICAL; MODELS, MOLECULAR; PHENYLALANINE; RANA PIPIENS; RECEPTORS, PITUITARY HORMONE; STEREOISOMERISM; STRUCTURE-ACTIVITY RELATIONSHIP; TRYPTOPHAN;

EID: 0030610607     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm970018t     Document Type: Article

References (45)

1. De Wied, D.; Jolles, J. Neuropeptides Derived from Pro-Opiocortin: Behavioral, Physiological, and Neurochemical Effects. Physiol. Rev. 1982, 62, 976-1059.
2. Vaudry, H., Eberle, A. N., Eds. The Melanotropic Peptides. Ann. N.Y. Acad. Sci. 1993, 680, 686.
3. Hruby, V. J.; Wilkes, B. C.; Cody, W. L.; Sawyer, T. K.; Hadley, M. E. Melanotropins: Structural, Conformational and Biological Considerations in the Development of Superpotent and Superprolonged Analogs. Pept. Protein Rev. 1984, 3, 1-64.
4. Hadley, M. E., Ed. The Melanotropic Peptides: Source, Synthesis, Chemistry, Secretion and Metabolism; CRC Press: Boca Raton, FL, 1989; Vols. I-III.
5. Eberle, A. N. The Melanotropins: Chemistry, Physiology and Mechanisms of Action; Karger: Basel, 1988.
6. Bagnara, J. T.; Hadley, M. E. Chromatophores and Color Change: The Comparative Physiology of Animal Pigmentation; Prentice Hall: Englewood Cliffs, NJ, 1972.
7. Hadley, M. E.; Sharma, S. D.; Hruby, V. J.; Levine, N.; Dorr, R. T. Melanotropic Peptides for Therapeutic and Cosmetic Tanning of the Skin. In Ann. N.Y. Acad. Sci. 1993, 680, 424-439.
8. Sawyer, T. K.; Sanfillippo, P. J.; Hruby, V. J.; Engel, M. H.; Heward, C. B.; Burnett, J. B.; Hadley, M. E. 4-Norleucine, 7-D-Phenylalanine-α-Melanocyte-Stimulating Hormone: A Highly Potent α-Melanotropin with Ultra Long Biological Activity. Proc. Natl. Acad. Sci. U.S.A. 1980, 77, 5754-5758.
9. Hadley, M. E.; Anderson, B.; Heward, C. B.; Sawyer, T. K.; Hruby, V. J. Calcium-Dependent Prolonged Effects on Melanophores of [4-Norleucine, 7-D-Phenylalanine]-α-Melanotropin. Science 1981, 213, 1025-1027.
10. Al-Obeidi, F.; Hadley, M. E.; Pettitt, B. M.; Hruby, V. J. Design of a New Class of Superpotent Cyclic α-Melanotropins Based on Quenched Dynamic Stimulations. J. Am. Chem. Soc. 1989, 111, 3413-3416.
11. Al-Obeidi, F.; Castrucci, A. M.; Hadley, M. E.; Hruby, V. J. Potent and Prolonged Acting Cyclic Lactam Analogues of α-Melanotropin: Design Based on Molecular Dynamics. J. Med. Chem. 1989, 32, 2555-2561.
12. 7] α-MSH: Discovery of a Tripeptidyl Agonist Exhibiting Sustained Bioactivity. In Ann. N.Y. Acad. Sci. 1993, 680, 597-599.
13. Haskell-Luevano, C.; Sawyer, T. K.; Hendrata, S.; North, C.; Panahinia, L.; Stum, M.; Staples, D. J.; Castrucci, A. M.; Hadley, M. E.; Hruby, V. J. Truncation Studies of α-Melanotropin Peptides Identifies Tripeptide Analogues Exhibiting Prolonged Agonist Bioactivity. Peptides 1996, 17, 995-1002.
14. 2 With Bulky Aromatic Amino Acids at Position 7 Show High Antagonist Potency and Selectivity at Specific Melanocortin Receptors. J. Med. Chem. 1995, 38, 3454-3461.
15. Haskell-Luevano, C.; Boteju, L. W.; Miwa, H.; Dickinson, C.; Gantz, I.; Yamada, T.; Hadley, M. E.; Hruby, V. J. Topographical Modifications of Melanotropin Peptide Analogues with β-Methyltryptophan Isomers at Position 9 Leads to Differential Potencies and Prolonged Biological Activities. J. Med. Chem. 1995, 38, 4720-4729.
16. Haskell-Luevano, C.; Boteju, L. W.; Miwa, H.; Job, C.; Al-Obeidi, F.; Gantz, I.; Hadley, M. E.; Hruby, V. J. Use of Topographical Modifications of Peptides to Examine Biological Mechanisms Such as Prolongation. In Peptides, Chemistry, Structure and Biology; Kaumaya, P. T. P., Hodges, R. S., Eds.; Mayflower Scientific Ltd: Kingswinford, England, 1996; pp 831-832.
17. Haskell-Luevano, C. Ph.D. Thesis, University of Arizona, 1995.
18. Goodman, M.; Ro, S. Peptidomimetics for Drug Design. In Burger's Medicinal Chemistry and Drug Discovery; Wolff, M. E., Eds.; Wiley: New York, 1995; Vol. 1: Principles and Practice, pp 803-861.
19. Hruby, V. J.; Al-Obeidi, F.; Kazmierski, W. Emerging Approaches In The Molecular Design of Receptor-Selective Peptide Ligands - Conformational, Topographical And Dynamic Considerations. Biochem. J. 1990, 268, 249-262.
20. Hruby, V. J. Conformational and Topographical Considerations in the Design of Biologically Active Peptides. Biopolymers 1993, 33, 1073-1082.
21. 3 Replacements in the Cyclic δ Receptor Selective Tetrapeptide Tyr-c[D-Cys-Phe-D-Pen]OH (JOM-13). J. Med. Chem. 1994, 37, 4384-4391.
22. Hruby, V. J.; Toth, G.; Gehrig, C. A.; Kao, L.; Knapp, R.; Lui, G. K.; Yamamura, H. I.; Kramer, T. H.; Davis, P.; Burks, T. F. Topographically Designed Analogues of c[D-Pen, D-Pen] enkephalin. J. Med. Chem. 1991, 34, 1823-1830.
23. Toth, G.; Russell, K. C.; Landis, G.; Kramer, T. H.; Fang, L.; Knapp, R.; Davis, P.; Burks, T. F.; Yamamura, H. I.; Hruby, V. J. Ring Substituted and Other Conformationally Constrained Tyrosine Analogues of [D-Pen2,D-Pen5]enkephalin with δ Opiod Receptor Selectivity. J. Med. Chem. 1992, 35, 2384-2391.
24. Qian, X.; Kövér, K. E.; Shenderovich, M. D.; Lou, B.; Misicka, A.; Zalewska, T.; Horváth, R.; Davis, P.; Bilsky, E. J.; Porreca, F.; Yamamura, H. I.; Hruby, V. J. Newly Discovered Stereochemical Requirements in the Side-Chain Conformation of δ Opiod Agonists for Recognizing Opioid d Receptors. J. Med. Chem. 1994, 37, 1746-1757.
25. 2. J. Med. Chem. 1995, 38, 585-586.
26. 2 on k Receptor Selectivity and Potency. J. Med. Chem. 1996, 39, 2456-2460.
27. Azizeh, B. Y.; Shenderovich, M. D.; Trivedi, D.; Li, G.; Sturm, N. S.; Hruby, V. J. Topographical Amino Acid Substitution in Position 10 of Glucagon Leads to Antagonists/Partial Agonists with Greater Binding Differences. J. Med. Chem. 1996, 39, 2449-2455.
28. Lebl, M.; Toth, G.; Slaninova, J.; Hruby, V. J. Conformationally Biased Analogs of Oxytocin. Int. J. Pept. Protein Res. 1992, 40, 148-151.
29. Köver, K. E.; Jiao, D.; Fang, S.; Hruby, V. J. Conformational Analysis of Four β-Methylphenylalanine Stereoisomers in a Bioactive Peptide by z-Filtered Relay NMR Spectroscopy. Magn. Reson. Chem. 1993, 31, 1072-1076.
30. Huang, Z.; He, Y.; Raynor, K.; Tallent, M.; Reisine, T.; Goodman, M. Main Chain and Side Chain Chiral Methylated Somatostatin Analogs: Syntheses and Conformation Analyses. J. Am. Chem. Soc. 1992, 114, 9390-9401.
31. Valle, G.; Kazmierski, W. M.; Crisma, M.; Bonora, G. M.; Toniolo, C.; Hruby, V. J. Constrained Phenylalanine Analogues Preferred Conformation of the 1,2,3,4-Tetrahydroisoquinoline-3-carboxylic Acid (Tic) Residue. Int. J. Pept. Protein Res. 1992, 40, 222-232.
32. Shizume, K.; Lerner, A. B.; Fitzpatrick, T. B. In Vitro Bioassay for the Melanocyte Stimulating Hormone. Endocrinology 1954, 54, 533-560.
33. Goldman, J. M.; Hadley, M. E. Evidence for Separate Receptors for Melanophore Stimulating Hormone and Catecholamine Regulation of Cyclic AMP in the Control of Melanophore Responses. Br. J. Pharmacol. 1970, 39, 160-166.
34. Vesely, D. L.; Hadley, M. E. Receptor-Specific Calcium Requirement for Melanophore-Stimulating Hormone. In Pigment Cell: Unique Properties of Melanocytes; Riley, V., Eds.; S. Karger: Basel, 1976; Vol. 3, 265-274.
35. Haskell-Luevano, C.; Boteju, L. W.; Hruby, V. J. Removal of the N-Indole-(Mesitylenesulfonyl) Protecting Group Using HF Cleavage Conditions. Lett. Pept. Sci. 1995, 1, 163-170.
36. Boteju, L. W.; Wegner, K.; Qian, X.; Hruby, V. J. Asymmetric Synthesis of Unusual Amino Acids: Synthesis of Optically Pure Isomers of N-Indole-(2-mesitylenesulfonyl)-β-methyltrypotphan. Tetrahedron 1994, 50, 2391-2404.
37. Qian, X.; Shenderovich, M. D.; Köver, K. E.; Davis, P.; Horwath, R.; Zalseska, T.; Yamamura, H. I.; Porreca, F.; Hruby, V. J. Probing the Stereochemical Requirement for Receptor Recognition at δ Opiod Agonists Through Topographical Modifications at Posisiton 1. J. Am. Chem. Soc. 1996, 118, 7280-7290.
38. Haskell-Luevano, C.; Shenderovich, M. D.; Sharma, S. D.; Nikiforovich, G. V.; Hadley, M. E.; Hruby, V. J. Design, Synthesis, Biology and Conformations of Bicyclic α-Melanotropin Peptide Analogues. J. Med. Chem. 1995, 38, 1736-1750.
39. Wilkes, B. C.; Sawyer, T. K.; Hruby, V. J.; Hadley, M. E. Differentiation of the Structural Features of Melanotropins Important for Biological Potency and Prolonged Activity in Vitro. Int. J. Pept. Protein Res. 1983, 22, 313-324.
40. Cody, W. L.; Mahoney, M.; Knittel, J. J.; Hruby, V. J.; Castrucci, A. M. L.; Hadley, M. E. Cyclic Melanotropins. 9. 7-D-Phenylalanine Analogues of the Active-Site Sequence. J. Med. Chem. 1985, 28, 583-588.
41. Suzuki, I.; Cone, R. D.; Im, S.; Nordlund, J.; Abdel-Malek, Z. A. Binding of Melanotropic Hormones to the Melanocortin Receptor MC1R on Human Melanocytes Stimulates Proliferation and Melanogenesis. Endocrinology 1996, 137, 1627-1633.
42. Haskell-Luevano, C.; Miwa, H.; Dickinson, C.; Hruby, V. J.; Yamada, T.; Gantz, I. Binding and cAMP Studies of Melanotropin Peptides with the Cloned Human Peripheral Melanocortin Receptor, hMC1R. Biochem. Biophys. Res. Commun. 1994, 204, 1137-1142.
43. Haskell-Luevano, C.; Miwa, H.; Dickinson, C.; Hadley, M. E.; Hruby, V. J.; Yamada, T.; Gantz, I. Characterizations of the Unusual Dissociation Properties of Melanotropin Peptides From the Melanocortin Receptor, hMC1R. J. Med. Chem. 1996, 39, 432-435.
44. Kaiser, E.; Colescott, R. L.; Bossinger, C. D.; Cook, P. I. Color Test for Detection of Free Terminal Amino Groups in the Solid-Phase Synthesis of Peptides. Anal. Biochem. 1970, 34, 595-598.
45. Wright, R. M.; Lerner, A. B. On the Movement of Pigment Granules in Frog Melanocytes. Endocrinology 1960, 66, 599-609.